Evidence map›Paper›PMID 34960621›Full record

ArticleViruses2021

West Nile Virus Vaccination Protects against Usutu Virus Disease in Mice.

Rebecca Salgado, Seth A Hawks, Francesca Frere, Ana Vázquez, Claire Y-H Huang, Nisha K Duggal

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Cross-Protection between West Nile Virus and Emerging Flaviviruses in Wild Birds.The American journal of tropical medicine and hygiene · 2025
    Article
  7. Article
  8. Review
  9. Herpesvirus and Subsequent Usutu Virus Infection in a Great Grey Owl (Animals : an open access journal from MDPI · 2024
    Article
  10. Review
  11. Article
  12. Epidemiology, surveillance and diagnosis of Usutu virus infection in the EU/EEA, 2012 to 2021.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2023
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Rebecca SalgadoDepartment of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, VA 24061, USA.
Seth A HawksDepartment of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, VA 24061, USA.
Francesca FrereDepartment of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, VA 24061, USA.
Ana VázquezNational Centre for Microbiology, Instituto de Salud Carlos III (ISCIII), CIBERESP, CIBER Epidemiology and Public Health, 28220 Madrid, Spain.ORCID 0000-0002-9872-3316
Claire Y-H HuangArboviral Diseases Branch, Centers for Disease Control and Prevention, Division of Vector-Borne Diseases, Fort Collins, CO 80521, USA.ORCID 0000-0002-9720-4792
Nisha K DuggalDepartment of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, VA 24061, USA.
Virginia–Maryland College of Veterinary Medicine · USCenters for Disease Control and Prevention · USInstituto de Salud Carlos III · ES

Funding

RNAi Mediated Suppression of Hepatitis B ReplicationU01AI053988 · NIAID · NUCLEONICS, INC. · PI PACHUK, CATHERINE J · 2003 to 2007
$1.5M
Evolution and pathogenesis of Usutu virus, an emerging arbovirusR21AI153988 · NIAID · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI DUGGAL, NISHA · 2021 to 2022
$423k
National Institute of Allergy and Infectious Diseases AI53988NIAID NIH HHS R21 AI153988
6 · The paper itself

Abstract

West Nile virus (WNV) and Usutu virus (USUV) are mosquito-borne flaviviruses that can cause neuroinvasive disease in humans. WNV and USUV circulate in both Africa and Europe and are closely related. Due to antigenic similarity, WNV-specific antibodies and USUV-specific antibodies have the potential to bind heterologous viruses; however, it is unclear whether this interaction may offer protection against infection. To investigate how prior WNV exposure would influence USUV infection, we used an attenuated WNV vaccine that contains the surface proteins of WNV in the backbone of a dengue virus 2 vaccine strain and protects against WNV disease. We hypothesized that vaccination with this attenuated WNV vaccine would protect against USUV infection. Neutralizing responses against WNV and USUV were measured in vitro using sera following vaccination. Sera from vaccinated CD-1 and

Indexed as

AnimalsAntibodies, NeutralizingAntibodies, ViralFemaleFlavivirusFlavivirus InfectionsMaleMiceMice, KnockoutVaccinationWest Nile Virus VaccinesAntibodies, NeutralizingAntibodies, ViralWest Nile Virus Vaccinesflavivirusneutralizing responseUsutu virusvaccineWest Nile virus

Identifiers

PMID34960621
PMCPMC8704473
OpenAlexW3216184591

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.